The 5-HT3 receptor--the relationship between structure and function
- PMID: 18761359
- PMCID: PMC6485434
- DOI: 10.1016/j.neuropharm.2008.08.003
The 5-HT3 receptor--the relationship between structure and function
Abstract
The 5-hydroxytryptamine type-3 (5-HT3) receptor is a cation-selective ion channel of the Cys-loop superfamily. 5-HT3 receptor activation in the central and peripheral nervous systems evokes neuronal excitation and neurotransmitter release. Here, we review the relationship between the structure and the function of the 5-HT3 receptor. 5-HT3A and 5-HT3B subunits are well established components of 5-HT3 receptors but additional HTR3C, HTR3D and HTR3E genes expand the potential for molecular diversity within the family. Studies upon the relationship between subunit structure and the ionic selectivity and single channel conductances of 5-HT3 receptors have identified a novel domain (the intracellular MA-stretch) that contributes to ion permeation and selectivity. Conventional and unnatural amino acid mutagenesis of the extracellular domain of the receptor has revealed residues, within the principle (A-C) and complementary (D-F) loops, which are crucial to ligand binding. An area requiring much further investigation is the subunit composition of 5-HT3 receptors that are endogenous to neurones, and their regional expression within the central nervous system. We conclude by describing recent studies that have identified numerous HTR3A and HTR3B gene polymorphisms that impact upon 5-HT3 receptor function, or expression, and consider their relevance to (patho)physiology.
Figures

Similar articles
-
The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.Biochem Soc Trans. 2004 Jun;32(Pt3):547-52. doi: 10.1042/BST0320547. Biochem Soc Trans. 2004. PMID: 15157181 Review.
-
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia.Pharmacogenet Genomics. 2009 Nov;19(11):843-51. doi: 10.1097/FPC.0b013e3283313296. Pharmacogenet Genomics. 2009. PMID: 19794330 Clinical Trial.
-
Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptors.Biochem Soc Trans. 2006 Nov;34(Pt 5):882-6. doi: 10.1042/BST0340882. Biochem Soc Trans. 2006. PMID: 17052220
-
Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry.Mol Pharmacol. 2019 Dec;96(6):720-734. doi: 10.1124/mol.119.116657. Epub 2019 Oct 3. Mol Pharmacol. 2019. PMID: 31582575
-
Serotonin type 3 receptor genes: HTR3A, B, C, D, E.Pharmacogenomics. 2008 May;9(5):501-4. doi: 10.2217/14622416.9.5.501. Pharmacogenomics. 2008. PMID: 18466097 Review.
Cited by
-
Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT3 receptor currents in NCB-20 cells.Korean J Physiol Pharmacol. 2019 Nov;23(6):509-517. doi: 10.4196/kjpp.2019.23.6.509. Epub 2019 Oct 24. Korean J Physiol Pharmacol. 2019. PMID: 31680773 Free PMC article.
-
Migraine signaling pathways: amino acid metabolites that regulate migraine and predispose migraineurs to headache.Mol Cell Biochem. 2022 Sep;477(9):2269-2296. doi: 10.1007/s11010-022-04438-9. Epub 2022 Apr 28. Mol Cell Biochem. 2022. PMID: 35482233 Review.
-
Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state.Endocrinology. 2015 Feb;156(2):444-52. doi: 10.1210/en.2014-1687. Epub 2014 Nov 26. Endocrinology. 2015. PMID: 25426873 Free PMC article.
-
Running Reverses Chronic Stress-Induced Changes in Serotonergic Modulation of Hippocampal Granule Cells and Altered Behavioural Responses.Eur J Neurosci. 2025 Apr;61(7):e70084. doi: 10.1111/ejn.70084. Eur J Neurosci. 2025. PMID: 40165404 Free PMC article.
-
5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice.Anesthesiology. 2011 May;114(5):1180-9. doi: 10.1097/ALN.0b013e31820efb19. Anesthesiology. 2011. PMID: 21368652 Free PMC article.
References
-
- Abi-Dargham A, Laruelle M, Wong DT, Robertson DW, Weinberger DR, Kleinman JE. Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain. J. Neurochem. 1993;60:730–737. - PubMed
-
- Akuzawa S, Miyake A, Miyata K, Fukutomi H. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors. Eur. J. Pharmacol. 1996;296:227–230. - PubMed
-
- Barnes JM, Barnes NM, Costall B, Ironside JW, Naylor RJ. Identification and characterisation of 5-hydroxytryptamine3 recognition sites in human brain tissue. J. Neurochem. 1989;53:1787–1793. - PubMed
-
- Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ. Characterisation and autoradiographic localisation of the 5-HT3 receptor recognition sites identified with [3H]-(s)-zacopride in the forebrain of the rat. Neuropharmacology. 1990;29:1037–1045. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous